BrainStorm Cell Therapeutics
BCLI
#10185
Rank
ยฃ5.08 M
Marketcap
ยฃ0.89
Share price
-6.50%
Change (1 day)
-88.44%
Change (1 year)

Revenue for BrainStorm Cell Therapeutics (BCLI)

Revenue in 2024 (TTM): N/A

In 2022 the company made a revenue of N/A a decrease over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BrainStorm Cell Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ22.29 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ14.32 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.78 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.50 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ80.23 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ87.44 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA